BRCA1 and breast cancer: Germline BRCA1/2 mutations are associated with increased susceptibility to EOC and breast cancer [32], with a lifetime risk of developing EOC estimated at 40–60% for BRCA1 and 11–27% for BRCA2 mutation carriers, compared with 1.3% of women in the general population [2,33].